The LMG Life Sciences Awards has released the full list of finalists for the 2023 EMEA awards.
The awards bring together Europe’s legal community to recognise the leading law firms and lawyers from across the region to celebrate their success in the Life Sciences industry.
Winners will be announced at the black-tie gala celebration which will be held on 13 July 2023 at the Waldorf Hilton.
A preview of the finalists can be found below and the full list of the finalists for all categories is available on the LMG Life Sciences website. The LMG Life Sciences Awards research team carefully selected each finalist after a thorough research period which included an analysis of direct submissions, client feedback, and much deliberation.
Individual practitioners and Rising Stars are judged not only on the complexity of the work the nominees completed in 2022, but also on their advocacy, influence, and thought leadership.
All of the work accepted for shortlisting closed during the research period, which was from January 1 to December 31 2022. The awards do not recognise cases, deals, or transactions completed outside of the research period.
If you have any questions regarding our research process, please contact our editor John Harrison
The LMG Life Sciences Awards will be announcing the winners on July 13 at a live awards gala. To find out more – and to find out about how you can promote your success – please contact Prin Shasiharan.
Preview of the LMG Life Sciences Awards EMEA 2023 shortlist:
-
Allen & OveryCarpmaels & RansfordDORDAHerbert Smith FreehillsPestalozzi Attorneys at LawPowell GilbertTaylor Wessing
-
Bird & BirdDeris Attorney at Law PartnershipDimitrov Petrov & CoGreenberg TraurigKiortsis & AssociatesNSN Law FirmThe Luzzatto Group
-
Andreas SelingDORDAAndri HessHomburgerDavid WilsonCarpmaels & RansfordEmre Kerim YardimciDeris Attorney at Law PartnershipLaura OrlandoHerbert Smith FreehillsPatricia CappuynsTaylor WessingZoe ButlerPowell Gilbert
LMG Life Sciences is a sister publication to Managing IP, and is run independently from IP Stars research.